BMS-986322

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986322, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis [Phase 2]

See pricing